ArticleCancers2020

Synergistic Anti-Tumour Effect of Syk Inhibitor and Olaparib in Squamous Cell Carcinoma: Roles of Syk in EGFR Signalling and PARP1 Activation.

Duen-Yi Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.